compounded tirzepatide with b12 B12: Boost energy, maximize weight loss ConsumerLab | GLP-1 with B-12?

This is an FDA approved drug

However, because Semaglutide still acts on the same pathways, it is possible for non-diabetic individuals to notice some changes in body temperature, albeit potentially milder than those experienced by diabetic patients

The same Novo Nordisk-funded randomized controlled trial of nearly 2,000 overweight or obese non-diabetic adults also reported their visceral or belly fat was less than at baseline with semaglutide, as was their total fat mass

GLP-1 medications slow gastric emptying food sits in your stomach longer

Gypenosides reduced the risk of overweight and insulin resistance in C57BL/6J mice through modulating adipose thermogenesis and gut microbiota

Cardio does some of this too, but not all of it and not always to the same degree